CMS is soliciting comments on proposed changes to the 2013 Part D drug plan reporting requirements in the areas of (1) unused drugs in long-term care, and (2) medication therapy management programs. Comments will be accepted until January 31, 2011. CMS also has issued a memo to Part D sponsors regarding the processes that must be followed to update 2012 Part D plan formularies. Another recent memo announces that the collection of the Pharmaceutical Manufacturer Rebates, Discounts, and Other Price Concessions report is suspended for contract year 2011 because it duplicates data in the Part D sponsors’ Summary and Detailed DIR (direct and indirect remuneration) Report.